Innovation Efficiency of Chinese Pharmaceutical Manufacturing Industry from the Perspective of Innovation Ecosystem

Guan, Xueling; Chen, Lijiang; Xia, Qing; Qin, Zhaohui S.

doi:10.3390/su142012993

Cited by 6 publications

(4 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, [77] analyzed the performance of a sample of European pharmaceutical companies by using DEA (SFA model). [78] used DEA-Malmquist to evaluate pharmaceutical manufacturing companies in China.…”

Section: Related Workmentioning

confidence: 99%

Enhancing Efficiency Assessment of Egyptian Pharmaceutical Companies through the Usage of Two-Stage Uncertainty Data Envelopment Analysis Algorithm

El-Demerdash,

Ming,

Abelrahman

2024

Preprint

View full text Add to dashboard Cite

Evaluating the performance of pharmaceutical manufacturing companies is crucial for their success and competitiveness in the rapidly evolving Egyptian market. However, traditional data envelopment analysis (DEA) approaches often overlook the inherent uncertainty in the data, which can significantly impact efficiency assessments. To address this issue, this paper proposes a novel integrated DEA model to enhance the efficiency assessment of Egyptian pharmaceutical manufacturing companies. This two-stage framework effectively handles imprecise and ambiguous data, accommodating various forms of uncertainty, including fuzzy, stochastic, and neutrosophic data, alongside deterministic data. The results demonstrate that the proposed model outperforms traditional DEA models in capturing data uncertainty and providing more accurate efficiency evaluations.

show abstract

Section: Related Workmentioning

confidence: 99%

Enhancing Efficiency Assessment of Egyptian Pharmaceutical Companies through the Usage of Two-Stage Uncertainty Data Envelopment Analysis Algorithm

El-Demerdash,

Ming,

Abelrahman

2024

Preprint

View full text Add to dashboard Cite

show abstract

“…to test whether the odds ratio for a variable (X mi ) increased by one unit and the odds ratio without such an increase are equal [80]:…”

Section: Subject Explanatory Variablementioning

confidence: 99%

“…The above assumes particular importance in the sphere of R&D, as noted by X. Guan et al [80], and knowledge sharing more broadly-key determinants of pharmaceutical industry development.…”

mentioning

confidence: 96%

Pharmaceutical Companies in the Light of the Idea of Sustainable Development—An Analysis of Selected Aspects of Sustainable Management

Chomać-Pierzecka

2023

Sustainability

View full text Add to dashboard Cite

The strategy of creating value and increasing the competitiveness of economic entities under the idea of sustainable development entails the need to provide access to up-to-date knowledge, which is to strengthen the decision-making basis and increase the level of properties of economic decisions. This argument strengthens the legitimacy of undertaking a research problem, oriented towards an overview of contemporary business challenges in the light of sustainable development, to assess the direction of activities undertaken by enterprises in the economic and socio-environmental sphere in connection with their activities. The need to undertake sustainable activities—with an emphasis on the environmental aspect—is particularly relevant to the pharmaceutical industry, which, in implementing activities oriented towards the protection of human health and life in connection with drug production, treats the issue of concern for the health of the planet as an extremely important challenge. The literature on the subject generally and insufficiently discusses sustainability issues for companies operating in this industry. Recognising the pharmaceutical sector as an area of economy of key importance in the socio-economic dimension at the level of national economies and at the international level, it became reasonable to scientifically identify the indicated issues in relation to pharmaceutical industry enterprises, with particular emphasis on entities operating in Poland. Hence, the main aim of the study, in response to the diagnosed gap, was to assess the directions of improvement of business models of Polish pharmaceutical enterprises, with consideration given to determinants of sustainable development. This study draws attention to the significance of practical choices of pharmaceutical entities—determined by their activity strategy, on sustainable development, as well as the impact of performance on the practice of sustainable development in the light of the assessment of the companies’ managerial effectiveness, demonstrating their significant importance. The realisation of the objective was based on a thorough review of the literature on the topic explored, as well as on the results of a diagnostic survey conducted among Polish pharmaceutical companies. An in-depth analysis of the findings in the area explored was conducted using statistical testing, including statistical ordering of variables, variable correlation matrix, logistic regression, odds ratio, and PQstat software. The main conclusion of the study is the finding that the business models of Polish pharmaceutical enterprises are continuously improving towards increasing the level of sustainable development, and the main determinant for the realisation of the above is the development of innovation, strongly correlated with the category of particularly good results on operations, constituting their managerial effectiveness.

show abstract

“…Analogous to natural and social ecosystems, a regional innovation ecosystem is a dynamic and balanced system consisting of innovation producers, consumers, and the environment [23]. It aims to promote the sustainable development of regions (Figure 1).…”

Section: Theoretical Foundation and Research Model 21 Regional Innova...mentioning

confidence: 99%

Spatiotemporal Evolution and Cause Analysis of Innovation Ecosystem Niche Fitness: A Case Study of the Yellow River Basin

Zhang

Zhou

2023

Sustainability

View full text Add to dashboard Cite

In this study, we explore the evolution and formation mechanism of innovation ecosystem niche fitness from three perspectives: theoretical analysis, model construction, and empirical testing. Based on the niche theory, a theoretical framework for the innovation ecosystem is constructed. Spatiotemporal analysis and qualitative comparison methods are employed to estimate the innovation niche fitness of nine provinces located in the Yellow River Basin, and their spatiotemporal characteristics and differences in terms of formation mechanism differences are then explored. The results show that: (1) temporally, from 2000 to 2017, the innovation niche fitness in the Yellow River Basin experienced minor fluctuations. However, since 2017, there has been a considerable increase. Spatially, the midstream and downstream regions, particularly in the provinces of Shandong, Henan, and Sichuan, have a higher innovation fitness. Conversely, the upstream regions of Qinghai, Ningxia, Gansu, and Inner Mongolia display a lower fitness because of the lack of advantages in innovation elements. (2) The innovation niche fitness is heavily influenced by several factors, including the number of industrial enterprises above designated size, R&D personnel, higher education institutions, scientific research institutions, expenditure for technical renovation, sales revenue of new products, total expenditure on R&D, and the total retail sales of consumer goods. (3) Four mechanisms explain high innovation niche fitness, each of which corresponds to different regions. The formation mechanisms of low innovation niche fitness can be categorized into two paths, which have an asymmetric relationship with the formation mechanisms of high innovation niche fitness. Therefore, provinces and regions should focus on these advantages to enhance the innovation niche fitness. Our research will serve as a theoretical reference to enhance the overall innovation capacity of the Yellow River Basin in the future.

show abstract

Innovation Efficiency of Chinese Pharmaceutical Manufacturing Industry from the Perspective of Innovation Ecosystem

Cited by 6 publications

References 47 publications

Enhancing Efficiency Assessment of Egyptian Pharmaceutical Companies through the Usage of Two-Stage Uncertainty Data Envelopment Analysis Algorithm

Enhancing Efficiency Assessment of Egyptian Pharmaceutical Companies through the Usage of Two-Stage Uncertainty Data Envelopment Analysis Algorithm

Pharmaceutical Companies in the Light of the Idea of Sustainable Development—An Analysis of Selected Aspects of Sustainable Management

Spatiotemporal Evolution and Cause Analysis of Innovation Ecosystem Niche Fitness: A Case Study of the Yellow River Basin

Contact Info

Product

Resources

About